NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission, OpGen reported after the close of the market on Thursday that its preliminary fourth quarter revenues fell 24 percent from Q4 2015, even as full-year 2016 revenues rose 27 percent.

For the three months ended Dec. 31, 2016, OpGen expects revenues of $1.0 million, down from the $1.3 million the company reported a year ago. Full the full year, OpGen expects revenues of $4.0 million, up from $3.2 million in 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.